⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAGE News
Niagen Bioscience, Inc. Common Stock
Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases
businesswire.com
NAGE
Form 8-K
sec.gov
NAGE
Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference
businesswire.com
NAGE
Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science
businesswire.com
NAGE
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
businesswire.com
NAGE
The Benchmark Company Announces 4th Annual Consumer One-on-One Conference in New York City
globenewswire.com
SNEX
BJRI
CALM
DIN
FWRG
FRPT
JJSF
KRUS
LIND
MBUU
NAGE
ONEW
PATK
PAG
SAH
ANDE
CHEF
STKS
WEST
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
businesswire.com
NAGE
Form 8-K
sec.gov
NAGE
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
businesswire.com
NAGE
Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
businesswire.com
NAGE